
Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into a standardized relational database using an AI Data Integration Engine, delivering real-time, clean, and consistent data for actionable insights. The platform includes Rivia Spark, an AI-powered visual intelligence tool that transforms natural language queries into dynamic visualizations and patient-specific insights. Rivia's solutions enhance decision-making across medical and clinical science, safety monitoring, clinical operations, and executive oversight, reducing risks, costs, and accelerating time to market. Trusted by leading innovators like Alentis Therapeutics, Calypso Biotech, and Abcentra Therapeutics, Rivia positions itself as a leader in transforming clinical trial data into insights that drive therapeutic innovation globally.

Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into a standardized relational database using an AI Data Integration Engine, delivering real-time, clean, and consistent data for actionable insights. The platform includes Rivia Spark, an AI-powered visual intelligence tool that transforms natural language queries into dynamic visualizations and patient-specific insights. Rivia's solutions enhance decision-making across medical and clinical science, safety monitoring, clinical operations, and executive oversight, reducing risks, costs, and accelerating time to market. Trusted by leading innovators like Alentis Therapeutics, Calypso Biotech, and Abcentra Therapeutics, Rivia positions itself as a leader in transforming clinical trial data into insights that drive therapeutic innovation globally.
What they do: Unified data and AI analytics platform for clinical trials
Founded: 2022
Headquarters (reported): Canton of Zürich, Switzerland
Recent funding: Seed round announced 2024-06-12
Lead investor (seed): Speedinvest
Clinical trials data fragmentation and slow, inconsistent analytics for biotech and pharmaceutical decision-making
2022
Software Development
€3.0M
Seed round reported by Dealroom and Crunchbase; investors named include Speedinvest, Nina Capital, Amino Collective. Dealroom lists €3.0M for Jun 2024.
“Seed round led by Speedinvest with participation from Nina Capital and Amino Collective”
| Company |
|---|
About Rivia
Rivia is a data engine for clinical trial intelligence. It provides data infrastructure and AI-driven workflows for clinical trial teams, enabling biotechs to run studies more efficiently and to demonstrate which patients derive the greatest benefit from new therapies. Biopharma companies are the source of most therapeutic innovation, yet clinical development is frequently slowed by fragmented data and outdated tooling. Rivia delivers a real-time, integrated view across clinical trial data, improving both trial execution and the evaluation of new treatments.
Our goal is for Rivia to become the new standard infrastructure for modern drug development, bringing new therapies to market more successfully at a fraction of the cost.
The Role
As Rivia’s first dedicated marketing growth hire, you’ll be the engine behind our content and communication. Working closely with the founders, you’ll help us reach more biotech leaders by creating content that informs, engages, and generates leads. This is a hands-on role where you’ll write, post, and measure: building a repeatable growth engine from the ground up.
What Excites You
Responsibilities
What Excites Us
Our Values
At Rivia, we are committed to excellence, continuous learning, and the success of both our customers and our team. If you are driven to exceed targets, eager to shape the future of clinical trials, and passionate about making a meaningful difference in the biotech industry, Rivia is the place for you.